BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11916140)

  • 1. Carbonic anhydrase activity modulators: synthesis of inhibitors and activators incorporating 2-substituted-thiazol-4-yl-methyl scaffolds.
    Scozzafava A; Saramet I; Banciu MD; Supuran CT
    J Enzyme Inhib; 2001 Oct; 16(4):351-8. PubMed ID: 11916140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines.
    Parkkila S; Vullo D; Puccetti L; Parkkila AK; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3955-9. PubMed ID: 16730978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activators.
    Rami M; Winum JY; Supuran CT; Melnyk P; Yous S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):224-229. PubMed ID: 30734616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines.
    Vullo D; Innocenti A; Nishimori I; Scozzafava A; Kaila K; Supuran CT
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4107-12. PubMed ID: 17540561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV.
    Temperini C; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
    Bioorg Med Chem Lett; 2007 Feb; 17(3):628-35. PubMed ID: 17127057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols.
    Innocenti A; Hilvo M; Scozzafava A; Parkkila S; Supuran CT
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3593-6. PubMed ID: 18501600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.
    Klinger AL; McComsey DF; Smith-Swintosky V; Shank RP; Maryanoff BE
    J Med Chem; 2006 Jun; 49(12):3496-500. PubMed ID: 16759092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.
    Temperini C; Scozzafava A; Vullo D; Supuran CT
    Chemistry; 2006 Sep; 12(27):7057-66. PubMed ID: 16807956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides.
    Shank RP; McComsey DF; Smith-Swintosky VL; Maryanoff BE
    Chem Biol Drug Des; 2006 Aug; 68(2):113-9. PubMed ID: 16999776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
    Temperini C; Scozzafava A; Puccetti L; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR studies on the activation of the human carbonic anhydrase cytosolic isoforms I and II and secretory isozyme VI with amino acids and amines.
    Singh J; Shaik B; Singh S; Sikhima S; Agrawal VK; Khadikar PV; Supuran CT
    Bioorg Med Chem; 2007 Oct; 15(20):6501-9. PubMed ID: 17689086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase activators. Activation of the membrane-associated isoform XV with amino acids and amines.
    Innocenti A; Hilvo M; Parkkila S; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3430-3. PubMed ID: 19464888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV.
    Di Fiore A; Monti SM; Innocenti A; Winum JY; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3601-5. PubMed ID: 20472429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfamates and their therapeutic potential.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Med Res Rev; 2005 Mar; 25(2):186-228. PubMed ID: 15478125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions.
    Vullo D; Ruusuvuori E; Kaila K; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3139-43. PubMed ID: 16621537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.